Anthony Fauci is scheduled to appear Wednesday before a Senate committee led by Sen. Rand Paul, who is expected to press the former federal health official over disputed testimony, U.S.-funded coronavirus research and the legal implications of his presidential pardon.
By yourNEWS Media Newsroom
Former National Institute of Allergy and Infectious Diseases Director Anthony Fauci is scheduled to testify Wednesday before the Senate Homeland Security and Governmental Affairs Committee, where Chairman Rand Paul, R-Ky., is expected to scrutinize Fauci’s prior statements about federally funded coronavirus research and the government’s response to the COVID-19 pandemic.
The hearing follows a subpoena issued by Paul and is scheduled to begin at 8:30 a.m. in the Dirksen Senate Office Building. Fauci, 85, is expected to face questions about National Institutes of Health grants awarded to EcoHealth Alliance, experiments conducted at the Wuhan Institute of Virology and whether his previous testimony accurately described the nature of that research.
Paul and other congressional Republicans have repeatedly accused Fauci of misleading Congress under oath during a May 2021 hearing. Fauci testified at the time that the NIH “has not ever and does not now fund gain-of-function research in the Wuhan Institute of Virology.”
The dispute centers on NIH funding provided to EcoHealth Alliance, which supported research at the Chinese laboratory involving bat coronaviruses that were modified and studied for their ability to infect human cells.
Fauci and other NIH officials have defended the earlier testimony by distinguishing between a broad scientific understanding of gain-of-function research and the agency’s narrower regulatory definition involving enhanced potential pandemic pathogens subject to specialized federal review.
That distinction became a central point of contention during congressional investigations into the origin of COVID-19 and the government’s oversight of research conducted through EcoHealth Alliance.
In May 2024, then-acting NIH Director Lawrence Tabak testified that the agency had funded research at the Wuhan laboratory that could be characterized as gain-of-function under a general definition. Tabak maintained, however, that the experiments did not fall within the narrower category governed by the NIH’s regulatory framework.
The acknowledgment intensified criticism of Fauci’s 2021 denial. It also came as the NIH removed the broader definition of gain-of-function research from its website amid the continuing controversy.
Wednesday’s hearing is likely to revisit the language used by Fauci and other officials, the standards applied when reviewing EcoHealth Alliance’s work and whether Congress received a complete and accurate account of the research.
Fauci’s legal position is further complicated by a preemptive pardon issued by former President Joe Biden covering conduct connected to Fauci’s federal service from 2014 through 2025.
Paul has questioned both the breadth of the pardon and the circumstances under which it was issued, including whether Biden personally approved and understood the action and whether an autopen was used.
“It’s an extraordinary pardon. It’s a pardon not for a specific crime, and it’s a pardon over a 10-year period for anything you might be accused of over that period,” Paul said.
“I think that could be challenged in court, because it’s not specific, it’s vague, and it doesn’t specify the crime, and it’s such a large period of time. So, I think it could be challenged, and should be challenged. I think the fact that it was signed by an auto pen could be challenged. Was President Biden of sound mind? Did he understand who he was pardoning? Did he participate in it? So, I would, I would take it to court.”
Paul has also called on the Justice Department to pursue felony charges against Fauci over alleged false statements to Congress. Paul has argued that bringing a case would allow a federal court to determine whether Biden’s pardon is legally valid and whether it covers the conduct at issue.
The senator has further contended that any new statements, evidence or conduct falling outside the pardon’s stated period or scope could create additional legal exposure.
Former federal prosecutor Jim Trusty said Fauci’s most immediate risk during the hearing may arise from the answers he gives Wednesday rather than from conduct already covered by the pardon.
“The biggest danger for him at this point won’t be some sort of substantive crime. It would be false statements,” Trusty told Newsmax. “He’s already given inconsistent statements over the years. So getting him to kind of rehash that could lead to some exposure.”
Trusty said the pardon could prevent Fauci from invoking the Fifth Amendment when questioned about matters for which the possibility of federal prosecution has been removed.
“I’m not a huge fan of the substitute of perjury traps for substantive investigations. But […] it’ll be interesting to see guys like Fauci, who have no Fifth Amendment privilege, having to endure some serious questioning,” Trusty said.
The Fifth Amendment protects witnesses from being compelled to provide testimony that could expose them to criminal prosecution. Under longstanding legal precedent, however, that privilege generally does not apply when a valid pardon has eliminated the risk of prosecution for the conduct being discussed.
That principle was addressed by the U.S. Supreme Court in Brown v. Walker, which concerned whether immunity from prosecution could remove a witness’s basis for refusing to testify.
Because Biden’s pardon covers federal offenses associated with Fauci’s official duties between 2014 and 2025, the former NIAID director may have difficulty asserting a valid Fifth Amendment privilege regarding conduct within that period. Any determination would depend on the scope and legal validity of the pardon as well as the specific questions posed during the hearing.
The pardon would not protect Fauci from prosecution for knowingly making new false statements during Wednesday’s testimony. Federal law separately prohibits materially false representations to Congress and other government investigators.
Paul is expected to examine whether Fauci’s previous descriptions of the Wuhan research were accurate, whether NIH officials relied on technical definitions to avoid acknowledging the nature of the experiments and whether EcoHealth Alliance complied with federal reporting and oversight requirements.
The hearing could also address Fauci’s broader public statements during the pandemic, including his representations about the possible origins of the virus and the extent of U.S. involvement in research conducted at the Wuhan Institute of Virology.
Fauci has consistently defended his conduct and denied lying to Congress. His supporters have argued that the dispute reflects differing scientific and regulatory definitions rather than deliberate deception.
Paul has rejected that explanation, maintaining that NIH-funded experiments increased the capabilities of bat coronaviruses and that Fauci’s categorical denial prevented Congress and the public from receiving a straightforward account of the work.
Wednesday’s appearance will place those competing claims before the committee under oath, with Fauci’s answers likely to shape the continuing congressional inquiry into pandemic-era research, federal grant oversight and the accuracy of testimony provided by senior public health officials.
Original article
Comments